Page last updated: 2024-08-24

amprenavir and HIV-Associated Lipodystrophy Syndrome

amprenavir has been researched along with HIV-Associated Lipodystrophy Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haugaard, SB1
Baldi, A; Chirianni, A; De Luca, A; Esposito, V; Gargiulo, M; Lucariello, A; Manente, L; Parrella, G; Parrella, R; Perna, A; Viglietti, R1

Reviews

1 review(s) available for amprenavir and HIV-Associated Lipodystrophy Syndrome

ArticleYear
Alteration in pancreatic islet function in human immunodeficiency virus.
    Endocrinology and metabolism clinics of North America, 2014, Volume: 43, Issue:3

    Topics: Carbamates; Furans; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Nelfinavir; Ritonavir; Sulfonamides

2014

Other Studies

1 other study(ies) available for amprenavir and HIV-Associated Lipodystrophy Syndrome

ArticleYear
Role of FAP48 in HIV-associated lipodystrophy.
    Journal of cellular biochemistry, 2012, Volume: 113, Issue:11

    Topics: Adaptor Proteins, Signal Transducing; Adipocytes; Alkynes; Animals; Antiretroviral Therapy, Highly Active; Benzoxazines; Calcineurin; Carbamates; Cell Differentiation; Cell Line; Cyclopropanes; Furans; Gene Expression; Glucocorticoids; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Indinavir; Mice; Saquinavir; Signal Transduction; Stavudine; Sulfonamides; Transfection

2012